Session Details

[1SP-25]8. Biology of Diseases Ⅱ

Tue. Dec 1, 2026 2:00 PM - 3:00 PM JST
Tue. Dec 1, 2026 5:00 AM - 6:00 AM UTC
Room 25 (Exhibition Hall Open Stage)
Presentation Time: 3 minutes (2 min 30 sec for presentation, and 30 sec for transition)

[1SP-25-01 (1P-0539)]Comparative analysis of cell tropism and spike protein function between a newly isolated bovine coronavirus strain and the Kakegawa strain

○Yoshiro Sugiura1, Tohru Suziki2, Enkhjin Dorjsuren1, Tatsuki Takahashi1, Kenta Shimizu1, Sodbayasgalan Amarbayasgalan1, Shunji Yasuki1, Luo Like1, Taiki Okada1, Yanli Ma1, Wataru Kamitani1 (1.Department of Infectious Diseases and Host Defense, Graduate School of Medicine, Gunma University, 2.Laboratory of Veterinary Microbiology, Department of Veterinary Medicine, College of Bioresource Sciences, Nihon University)
Comment()

[1SP-25-02 (1P-0585)]Molecular mechanisms that control RTEL1 gene expression and telomerase activity after rapamycin treatment of HeLa S3 cells

○Takahiro Oda1, Shigeru Hanamata1, Fumiaki Uchiumi1 (1.Department of Gene Regulation, Graduate School of Pharmaceutical Science, Tokyo University of Science)
Comment()

[1SP-25-03 →演題取下げ Withdraw]Withdraw

Comment()

[1SP-25-04 (1P-0563)]A Novel Dysferlin-Binding Kinase CK2α Promotes Plasma Membrane Repair in Dysferlinopathy

○Muliang Rui1, Naoki Suzuki1, Naoko Nakamura1, Fangce Zhang1, Rumiko Izumi1, Ryuhei Harada1, Katsuya Miyake2, Masashi Aoki1, Satoru Ebihara1 (1.Grad. Sch. of Med., Tohoku Univ., 2.Sch. of Health Sci. at Narita, IUHW)
Comment()

[1SP-25-05 (1P-0494)]Effects of combined blue light and ionizing radiation on the proliferation of human cancer and endothelial cells.

○Keita Kitano1, Kosuke Kawanami2, Ryosuke Kajimoto2, Eichi Tsuruga1, Hironori Yoshino1 (1.Grad. Sch. of Health Sci., Univ. of Hirosaki, 2.Sch. of Health Sci., Univ. of Hirosaki)
Comment()

[1SP-25-06 (1P-0495)]Implications for Tumor Recurrence in Doxorubicin-Induced Stress and Tunneling Nanotube Formation in Breast Cancer Cells

○Helly Ketankumar Shah1,2, Rhydham Milan Karnik1,2, Deepak Modi3, Ranjitsinh Devkar1,2 (1.Chronobiology and Metabolic Endocrinology Lab, Department of Zoology, Faculty of Science, The M.S. University of Baroda, Vadodara, INDIA, 2.Dr. Vikram Sarabhai Institute of Cell and Molecular Biology, Faculty of Science, The M.S. University of Baroda, Vadodara, INDIA, 3.Department of Molecular and Cellular Biology, ICMR-National Institute for Research in Reproductive Health)
Comment()

[1SP-25-07 (1P-0586)]An individualized gene network framework for dissecting heterogeneous skeletal muscle exercise responses

○Mashiro Yasuda1, Hirotaka Iijima2 (1.Fac. of Med., Univ. of Tokyo, 2.Dept. of PM&R, Harvard Medical School)
Comment()

[1SP-25-08 (1P-0599)]Investigating the Role of Type 2 Inflammation in Moyamoya Disease Using Patient-Derived iPSC Vascular Models

○Kota Nakajima1,2, Silsu Park1,10, Makoto Ikeya2, Maria Jose Lopez Iniesta3, Yuki Oichi1,11, Yuji Agawa1,12, Miki Yoshioka4, Wataru Fujibuchi5, Knut Woltjen6, Jun K Yamashita5, Tohru Tezuka7, Shohab Youssefian8, Akio Koizumi9, Yoshiki Arakawa1, Yohei Mineharu1,3 (1.Dep. of Neurosurgery, Grad. Sch. of Med., Kyoto Univ., 2.Dep. of Clinical Application, CiRA, Kyoto Univ., 3.Health and Medical DX Course, Grad. Sch. of Med., Kyoto Univ., 4.CiRA, Kyoto Univ., 5.Dep. of Cell and Tissue Communication, Grad. Sch. of Med., Univ. of Tokyo, 6.Dep. of Life Science Frontiers, CiRA, Kyoto Univ., 7.Center for Medical Education and Internationalization, Grad. Sch. of Med., Kyoto Univ. , 8.Dep. of Molecular Biosciences, Grad. Sch. of Med., Kyoto Univ., 9.Kyoto Hokenkai, 10.Dep. of Neurosurgery, Kokura Memorial Hosp., 11.Dep. of Neurosurgery, Hyogo Pref. Amagasaki General Medical Center, 12.Dep. of Neurosurgery, Medical Research Institute KITANO HOSPITAL, PIIF Tazuke-kofukai)
Comment()

[1SP-25-09 (1P-0564)]Establishment of a Functional Evaluation System for Assessing the Pathogenic Significance of SLC16A1 Variants Reported in MCT1 Deficiency

○Emi Inoue1, Seina Nagae2, Ai Inagaki2, Mai Mori3, Hideki Matsumoto3, Hideo Sasai3, Yuka Aoyama1,2,3 (1.Grad. Sch. of Life and Health Sci., Chubu Univ., 2.Dept. of Clin. Eng., Coll. of Life and Health Sci., Chubu Univ, 3.Dept. of Pediatr., Grad. Sch. of Med., Gifu Univ.)
Comment()

[1SP-25-10 (1P-0587)]AI-driven Discovery of the Optimal Anti-Aging Compounds for Various Mechanisms

○Taiki Yamamura1, Takumi Ito2,3, Hideyuki Shimizu2,3 (1.School of Medicine, Institute of Science Tokyo, 2.Department of AI Systems Medicine, M&D Data Science Center, Institute of Integrated Research, Institute of Science Tokyo, 3.Graduate School of Medical and Dental Sciences, Institute of Science Tokyo)
Comment()

[1SP-25-11 (1P-0565)]Screening and evaluation of isoliquiritigenin derivatives targeting aberrant activation of the CAPS-associated NLRP3-D303N mutant

○Reiji Ogawa1, Miho Ito1, Hiroe Honda2, Tadayoshi Karasawa3, Fumitake Usui-Kawanishi1, Yoshinori Nagai1 (1. Grad. Sch. of Eng., Biotechnology, Toyama Pref. Univ., 2.Toyama Pref. Inst. Pharm. Res., 3.Div. Inflammation Res., Ctr. Mol. Med., Jichi Med. Univ.)
Comment()

[1SP-25-12 (1P-0496)]Human pancreatic stellate cells induce chemoresistance in human normal pancreatic ductal cells

○Koki Kamo Kamo1, Tatsuya Kometani1 (1.Dept. of Biosci., Tokyo Univ. of Agric.)
Comment()

[1SP-25-13 (1P-0517)]Structural development and inhibitory activity evaluation of isoliquiritigenin derivatives targeting aberrant activation of the CAPS-associated NLRP3-L353P mutant

○Miho Ito1, Reiji Ogawa1, Hiroe Honda2, Tadayoshi Karasawa3, Fumitake Usui-Kawanishi1, Masafumi Takahashi3, Yoshinori Nagai1 (1.Toyama Prefectural Univ., 2.Toyama Pref. Inst. Pharm. Res., 3.Div. Inflammation Res.,Ctr. Mol. Med., Jichi Med. Univ.)
Comment()

[1SP-25-14 (1P-0518)]IL-33 promotes mast cell granule biogenesis to amplify IgE-dependent allergic responses

○Haruka Mimura1, Naoto Ito1, Cristina Sebastia1, Yasuyo Harada1, Yasutaka Motomura1 (1.Tokyo University of Science)
Comment()

[1SP-25-15 (1P-0497)]Early-stage cancer cachexia models of feline oral squamous cell carcinoma and canine bladder cancer reveal adipose tissue metabolic reprogramming

○Yishan LIU1, Feiyang LIU1, Tatsuya Usui1, Ryouichi Tsunedomi2, Kazuaki Sasaki1 (1.Department of Veterinary Medicine, Faculty of Agriculture, Tokyo University of Agriculture and Technology, 2.2.OKAYAMA UNIVERSITY OF SCIENCE, Department of Veterinary Medicin)
Comment()

[1SP-25-16 (1P-0588)]Suppression of HNE-induced hepatic stellate cell senescence by nicotinamide mononucleotide and identification of a candidate NAD booster

○Tomofumi Saka1, Riri Hayashi2, Yuya Tsuchiya3, Masashi Kato3, Taichi Mitsui3, Hiroe Maruyama3, Hiroyuki Kono3, Yuta Yoshino1, Akira Ikari1, Satoshi Endo2,4,5 (1.Fac. of Pharm., Gifu Pharm. Univ., 2.United Grad. Sch. of Drug Discovery and Med. Info. Sci., Gifu Univ., 3.API Corp., 4.COMIT, Gifu Univ., 5.PFRC, Gifu Univ.)
Comment()

[1SP-25-17 (1P-0519)]Exploring the Mechanisms Underlying Th17 Cell Induction by Dietary Fibers

○Yurika Arai1, Takuto Kurakawa1, Seita Chudan1, Yoshinori Nagai1, Shinichi Ikusiro1, Yukihiro Furusawa1 (1.Toyama Prefectural University)
Comment()

[1SP-25-18 (1P-0498)]Nectin-4-Targeted Alpha Therapy with 211At-Labeled VHH-Funtionalized Gold Nanoparticles for Pancreatic Cancer

○HSIN-HUA HSIEH1, Kazuya Kabayama1,2,3 (1.Institute for Radiation Sciences, The University of Osaka, 2.Department of Chemistry, Graduate School of Science, The University of Osaka,, 3.FRC, Graduate School of Science, The University of Osaka)
Comment()